Table 1 Characteristic of the study subjects
Variables | Total (n = 1206) | Non-FDR (n = 957) | FDR (n = 249) |
|---|---|---|---|
Age (years) | 59.7 (54.8–64.3) | 59.9 (54.8–64.4) | 59.0 (54.0–63.2) |
Men, n (%) | 413 (34.2) | 337 (35.2) | 76 (30.5) |
BMI (kg/m2) | 24.0 ± 3.2 | 24.0 ± 3.2 | 24.2 ± 3.3 |
W (cm) | 82.0 (77.0–89.0) | 82.0 (77.0–88.0) | 83.0 (77.0–89.8) |
SBP (mmHg) | 129.0 (118.0–141.0) | 130.0 (119.0–142.0) | 124.0 (114.0–137.0) ** |
DBP (mmHg) | 77.0 (70.0–84.0) | 77.0 (71.0–85.0) | 75.0 (68.0–82.0) ** |
FPG (mmol/L) | 5.7 ± 0.5 | 5.7 ± 0.5 | 5.7 ± 0.5 |
2hPG (mmol/L) | 7.0 ± 1.8 | 7.0 ± 1.7 | 7.2 ± 1.8* |
HbA1c (%) | 5.6 (5.4–5.9) | 5.6 (5.4–5.8) | 5.7 (5.5–5.9) ** |
HOMA-IR | 2.2 (1.5–3.2) | 2.2 (1.5–3.1) | 2.2 (1.5–3.3) |
TC (mmol/L) | 5.4 (4.8–6.0) | 5.4 (4.8–6.0) | 5.3 (4.8–6.1) |
TG (mmol/L) | 1.4 (1.0–1.9) | 1.4 (1.0–1.9) | 1.4 (1.1–2.0) |
HDL-C (mmol/L) | 1.4 (1.2–1.7) | 1.4 (1.2–1.7) | 1.4 (1.2–1.7) |
LDL-C (mmol/L) | 3.3 (2.8–3.8) | 3.3 (2.8–3.8) | 3.3 (2.8–3.9) |
CRP (mg/L) | 0.9 (0.4–1.6) | 0.9 (0.4–1.6) | 0.9 (0.5–1.7) |
ALT (U/L) | 18.0 (14.0–24.0) | 18.0 (14.0–24.0) | 18.0 (14.0–24.0) |
AST (U/L) | 20.0 (18.0–24.0) | 20.0 (18.0–24.0) | 20.0 (17.5–24.0) |
GGT (U/L) | 22.0 (17.0–31.0) | 22.0 (17.0–32.0) | 22.0 (16.0–30.0) |
LFC (%) | 8.2 (6.6–22.2) | 8.2 (6.6–22.6) | 8.4 (6.6–16.2) |
NAFLD, n (%) | 479 (39.7) | 379 (39.6) | 100 (40.2) |
Impaired glucose regulation, n (%) | 513 (42.5) | 392 (41.0) | 121 (48.6) * |